Surgical Outcomes of da Vinci XiTM and da Vinci SPTM for Early-Stage Endometrial Cancer in Patients Undergoing Hysterectomy

Motoki Matsuura,Sachiko Nagao,Shoko Kurokawa,Masato Tamate,Taishi Akimoto,Tsuyoshi Saito
DOI: https://doi.org/10.3390/jcm13102864
IF: 3.9
2024-05-14
Journal of Clinical Medicine
Abstract:Objectives: This study aimed to evaluate and compare the feasibility and outcomes of two robotic hysterectomy (da Vinci XiTM vs. da Vinci SPTM) systems without lymph node dissection in patients with early-stage endometrial cancer, and assess the postoperative recurrence rate and overall survival of patients. Methods: A retrospective review of 84 patients who underwent robotic hysterectomy for endometrial cancer (stage 1A) was conducted. Surgical procedures, patient characteristics, intraoperative measures, and postoperative outcomes were statistically analyzed. A single gynecologist performed all surgeries. Results: Patient characteristics, average age, and body mass index showed no significant differences between the two models. The total operative time was significantly shorter with da Vinci SPTM. Recurrence was identified in only one patient operated on with da Vinci XiTM. All patients were alive during analysis, with a median overall survival of 38 and 9 months for da Vinci XiTM and da Vinci SPTM, respectively. Conclusions: Robotic hysterectomy without lymph node dissection appears to be a safe and effective approach for patients with early-stage endometrial cancer. The da Vinci SP offers the advantage of shorter operative times than the da Vinci XiTM. These findings support the consideration of robotic surgery as a viable option for selected patients.
medicine, general & internal
What problem does this paper attempt to address?